Quarterly report pursuant to Section 13 or 15(d)

Financing Arrangements (Tables)

v2.4.1.9
Financing Arrangements (Tables)
3 Months Ended
Mar. 31, 2015
Debt Disclosure [Abstract]  
Summary of carrying values and coupon rates on financing arrangements
The carrying values and the fixed contractual coupon rates of the Company's financing arrangements as of March 31, 2015 and December 31, 2014 were as follows (in thousands):

 
March 31, 2015
 
December 31, 2014
2019 Convertible Senior Notes
 
 
 
     Principal amount outstanding
$
245,000

 
$
245,000

     Unamortized discount
(46,781
)
 
(49,092
)
          Net carrying amount
198,219

 
195,908

Convertible notes payable, Viking Therapeutics, Inc.
348

 
334

Total notes payable
$
198,567

 
$
196,242